Magnetic Resonance Spectroscopy of the Breast at 3T: Pre- and Post-Contrast Evaluation for Breast Lesion Characterization

Purpose. To determine whether in vivo proton magnetic resonance spectroscopy at 3T can provide accurate breast lesion characterization, and to determine the effect of gadolinium on the resonance of tCho. Methods. Twenty-four positive-mammogram patients were examined on a 3T MR scanner. 1H-MRS was performed before and after gadolinium administration. tCho peak was qualitatively evaluated before and after contrast injection. Results. Fourteen out of 27 lesions proved to be malignant after histopathological diagnosis. Using 1H-MRS, before contrast injection, 6/14 confirmed malignancies and 11/13 benign lesions were correctly classified; while, after contrast injection, 11/14 confirmed malignancies and 12/13 benign processes were correctly classified. Post gadolinium 1H-MRS proved useful in picking up tCho signal, improving the overall accuracy, sensitivity, and specificity by 35%, 83%, and 9%, respectively. Conclusion. 1H-MRS overall accuracy, sensitivity, and specificity in detecting breast lesion's malignancy were increased after gadolinium administration. It is prudent to perform 1H-MRS before contrast injection in large breast lesions to avoid choline underestimation. In cases of small or non-mass lesions, it is recommended to perform 1H-MRS after contrast injection for better voxel prescription to enable a reliable preoperative diagnosis

Exsolved nickel nanoparticles acting as oxygen storage reservoirs and active sites for redox CH4 conversion

The growing demand for H2 and syngas requires the development of new, more efficient processes and materials for their production, especially from CH4 that is a widely available resource. One process that has recently received increased attention is chemical looping CH4 partial oxidation, which, however, poses stringent requirements on material design, including fast oxygen exchange and high storage capacity, high reactivity toward CH4 activation, and resistance to carbon deposition, often only met by composite materials. Here we design a catalytically active material for this process, on the basis of exsolution from a porous titanate. The exsolved Ni particles act as both oxygen storage centers and as active sites for CH4 conversion under redox conditions. We control the extent of exsolution, particle size, and population of Ni particles in order to tune the oxygen capacity, reactivity, and stability of the system and, at the same time, obtain insights into parameters affecting and controlling exsolution

Enhanced Stability of Iridium Nanocatalysts via Exsolution for the CO₂ Reforming of Methane

\ua9 2023 The Authors. Published by American Chemical Society. The reforming reactions of greenhouse gases require catalysts with high reactivity, coking resistance, and structural stability for efficient and durable use. Among the possible strategies, exsolution has been shown to demonstrate the requirements needed to produce appropriate catalysts for the dry reforming of methane, the conversion of which strongly depends on the choice of active species, its interaction with the support, and the catalyst size and dispersion properties. Here, we exploit the exsolution approach, known to produce stable and highly active nanoparticle-supported catalysts, to develop iridium-nanoparticle-decorated perovskites and apply them as catalysts for the dry reforming of methane. By studying the effect of several parameters, we tune the degree of exsolution, and consequently the catalytic activity, thereby identifying the most efficient sample, 0.5 atomic % Ir-BaTiO3, which showed 82% and 86% conversion of CO2 and CH4, respectively. By comparison with standard impregnated catalysts (e.g., Ir/Al2O3), we benchmark the activity and stability of our exsolved systems. We find almost identical conversion and syngas rates of formation but observe no carbon deposition for the exsolved samples after catalytic testing; such deposition was significant for the traditionally prepared impregnated Ir/Al2O3, with almost 30 mgC/gsample measured, compared to 0 mgC/gsample detected for the exsolved system. These findings highlight the possibility of achieving in a single step the mutual interaction of the parameters enhancing the catalytic efficiency, leading to a promising pathway for the design of catalysts for reforming reactions

Symmetrical Exsolution of Rh Nanoparticles in Solid Oxide Cells for Efficient Syngas Production from Greenhouse Gases

Carbon dioxide and steam solid oxide co-electrolysis is a key technology for exploiting renewable electricity to generate syngas feedstock for the Fischer–Tropsch synthesis. The integration of this process with methane partial oxidation in a single cell can eliminate or even reverse the electrical power demands of co-electrolysis, while simultaneously producing syngas at industrially attractive H2/CO ratios. Nevertheless, this system is rather complex and requires catalytically active and coke tolerant electrodes. Here, we report on a low-substitution rhodium-titanate perovskite (La0.43Ca0.37Rh0.06Ti0.94O3) electrode for the process, capable of exsolving high Rh nanoparticle populations, and assembled in a symmetrical solid oxide cell configuration. By introducing dry methane to the anode compartment, the electricity demands are impressively decreased, even allowing syngas and electricity cogeneration. To provide further insight on the Rh nanoparticles role on methane-to-syngas conversion, we adjusted their size and population by altering the reduction temperature of the perovskite. Our results exemplify how the exsolution concept can be employed to efficiently exploit noble metals for activating low-reactivity greenhouse gases in challenging energy-related applications.</p

Transcriptome-wide association study of schizophrenia and chromatin activity yields mechanistic disease insights

Genome-wide association studies (GWAS) have identified over 100 risk loci for schizophrenia, but the causal mechanisms remain largely unknown. We performed a transcriptome-wide association study (TWAS) integrating a schizophrenia GWAS of 79,845 individuals from the Psychiatric Genomics Consortium with expression data from brain, blood, and adipose tissues across 3,693 primarily control individuals. We identified 157 TWAS-significant genes, of which 35 did not overlap a known GWAS locus. Of these 157 genes, 42 were associated with specific chromatin features measured in independent samples, thus highlighting potential regulatory targets for follow-up. Suppression of one identified susceptibility gene, mapk3, in zebrafish showed a significant effect on neurodevelopmental phenotypes. Expression and splicing from the brain captured most of the TWAS effect across all genes. This large-scale connection of associations to target genes, tissues, and regulatory features is an essential step in moving toward a mechanistic understanding of GWAS

ZNHIT3 is defective in PEHO syndrome, a severe encephalopathy with cerebellar granule neuron loss

Progressive encephalopathy with oedema, hypsarrhythmia, and optic atrophy (PEHO) syndrome is an early childhood onset, severe autosomal recessive encephalopathy characterized by extreme cerebellar atrophy due to almost total granule neuron loss. By combining homozygosity mapping in Finnish families with Sanger sequencing of positional candidate genes and with exome sequencing a homozygous missense substitution of leucine for serine at codon 31 in ZNHIT3 was identified as the primary cause of PEHO syndrome. ZNHIT3 encodes a nuclear zinc finger protein previously implicated in transcriptional regulation and in small nucleolar ribonucleoprotein particle assembly and thus possibly to pre-ribosomal RNA processing. The identified mutation affects a highly conserved amino acid residue in the zinc finger domain of ZNHIT3. Both knockdown and genome editing of znhit3 in zebrafish embryos recapitulate the patients' cerebellar defects, microcephaly and oedema. These phenotypes are rescued by wild-type, but not mutant human ZNHIT3 mRNA, suggesting that the patient missense substitution causes disease through a loss-of-function mechanism. Transfection of cell lines with ZNHIT3 expression vectors showed that the PEHO syndrome mutant protein is unstable. Immunohistochemical analysis of mouse cerebellar tissue demonstrated ZNHIT3 to be expressed in proliferating granule cell precursors, in proliferating and post-mitotic granule cells, and in Purkinje cells. Knockdown of Znhit3 in cultured mouse granule neurons and ex vivo cerebellar slices indicate that ZNHIT3 is indispensable for granule neuron survival and migration, consistent with the zebrafish findings and patient neuropathology. These results suggest that loss-of-function of a nuclear regulator protein underlies PEHO syndrome and imply that establishment of its spatiotemporal interaction targets will be the basis for developing therapeutic approaches and for improved understanding of cerebellar development.Peer reviewe

Inhibition of Pediatric Glioblastoma Tumor Growth by the Anti-Cancer Agent OKN-007 in Orthotopic Mouse Xenografts

We thank the Peggy and Charles Stephenson Cancer Center at the University of Oklahoma, Oklahoma City, OK, for funding, who received an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under grant number P20 GM103639 for the use of the Histology and Immunohistochemistry Core for providing immunohistochemistry and photographic services. This work was also supported by Oklahoma State University, Center of Veterinary Health Science (Support Grant AE-1-50060 to P.C.S.), the Musella Foundation (R.A.T.), and the Childhood Brain Tumor Foundation (R.A.T.).Pediatric glioblastomas (pGBM), although rare, are one of the leading causes of cancer-related deaths in children, with tumors essentially refractory to existing treatments. Here, we describe the use of conventional and advanced in vivo magnetic resonance imaging (MRI) techniques to assess a novel orthotopic xenograft pGBM mouse (IC-3752GBM patient-derived culture) model, and to monitor the effects of the anti-cancer agent OKN-007 as an inhibitor of pGBM tumor growth. Immunohistochemistry support data is also presented for cell proliferation and tumor growth signaling. OKN-007 was found to significantly decrease tumor volumes (p<0.05) and increase animal survival (p<0.05) in all OKN-007-treated mice compared to untreated animals. In a responsive cohort of treated animals, OKN-007 was able to significantly decrease tumor volumes (p<0.0001), increase survival (p<0.001), and increase diffusion (p<0.01) and perfusion rates (p<0.05). OKN-007 also significantly reduced lipid tumor metabolism in responsive animals (Lip1.3 and Lip0.9)-to-creatine ratio (p<0.05), as well as significantly decrease tumor cell proliferation (p<0.05) and microvessel density (p<0.05). Furthermore, in relationship to the PDGFRα pathway, OKN-007 was able to significantly decrease SULF2 (p<0.05) and PDGFR-α (platelet-derived growth factor receptor-α) (p<0.05) immunoexpression, and significantly increase decorin expression (p<0.05) in responsive mice. This study indicates that OKN-007 may be an effective anti-cancer agent for some patients with pGBMs by inhibiting cell proliferation and angiogenesis, possibly via the PDGFRα pathway, and could be considered as an additional therapy for pediatric brain tumor patients.Yeshttp://www.plosone.org/static/editorial#pee